Saturday, August 29, 2015

Got back pain? Glucosamine won't help.

Chronic back pain in a common problem in the U.S. afflicting more than 20 million people. Many turn to the supplement glucosamine, despite little solid evidence that it helps people suffering from chronic back pain or joint pain caused by osteoarthritis. The researchers at Oslo University in Norway randomly assigned 250 people with chronic back pain due to osteoarthritis to two groups - one got the glucosamine and the other took placebos. The researchers reported "no statistically significant difference in change between groups was found when assessed after the 6-month intervention and at 1 year."

Got back pain? Glucosamine won’t help.

0 comments

Chronic back pain in a common problem in the U.S. afflicting more than 20  million people. Many turn to the supplement glucosamine, despite little solid evidence that it helps people suffering from chronic back pain or joint pain caused by osteoarthritis.

A study published in the current issue of the Journal of the American Medical Association reports that daily intake of 1,500 milligrams of the supplement for six months did not reduce “pain-related disability.”

The researchers at Oslo University in Norway randomly assigned 250 people with chronic back pain due to osteoarthritis to two groups – one got the glucosamine and the other took placebos. The researchers reported “no statistically significant difference in change between groups was found when assessed after the 6-month intervention and at 1 year.”

“Based on our results it seems unwise to recommend glucosamine to all patients with chronic [lower back pain] and degenerative lumbar osteoarthritis,” the researchers concluded.

To check out more Check Up items go to www.philly.com/checkup.

0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog

Check Up is a blog for savvy health consumers, covering the latest developments, discoveries, and debates from the Philadelphia area and beyond.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Charlotte Sutton Health and Science Editor, Philadelphia Inquirer
Tom Avril Inquirer Staff Writer, heart health and general science
Stacey Burling Inquirer Staff Writer, nueroscience and ageing
Marie McCullough Inquirer Staff Writer, cancer and women's health
Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Hooman Noorchashm, M.D., Ph.D. Cardiothoracic surgeon in the Philadelphia area
Amy J. Reed, M.D., Ph.D. Anesthesiologist and Surgical Intensivist in the Philadelphia Area
Latest Health Videos
Also on Philly.com:
letter icon Newsletter